Effects of repeated phencyclidine treatment on serotonin transporter in rat brain

Neuroscience Letters

Volumn 280, Issue 1, 2000, Pages 53-56

  Hori, Takafumi ^a   Abe, Shuzo ^a   Baba, Atsuomi ^a   Suzuki, Toshihito ^a   Shiraishi, Hiroyasu ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Paroxetine; Phencyclidine; Rat brain; Serotonin transporter; Stereotyped behavior; Tolerance

Indexed keywords

FLUOXETINE; PAROXETINE; PHENCYCLIDINE; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG TOLERANCE; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; SEROTONIN UPTAKE; SEROTONINERGIC TRANSMISSION; STEREOTYPY;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CARRIER PROTEINS; CELL MEMBRANE; DRUG ADMINISTRATION SCHEDULE; KINETICS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; PAROXETINE; PHENCYCLIDINE; RATS; RATS, WISTAR; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STEREOTYPED BEHAVIOR; TIME FACTORS; TRITIUM;

EID: 0033985674     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00991-X     Document Type: Article

References (23)

1. Balster R.L., Chait L.D. The behavioral pharmacology of phencyclidine. Clin. Toxicol. 9:1976;513-528.
2. Castellani S., Adams P.M. Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. Eur. J. Pharmacol. 73:1981;143-154.
3. 3H]5-HT uptake: effect of administration of various antidepressant treatments. Neuropharmacology. 32:1993;737-743.
4. Freeman A.S., Martin B.R., Balster R.L. Relationship between the development of behavioral tolerance and the biodisposition of phencyclidine in mice. Pharacol. Biochem. Behav. 20:1984;373-377.
5. Gorelick D.A., Balster R.L. Phencyclidine. Bloom F.E., Kupfer D.J. Psychopharmacology. 4th edn. 1995;1767-1776.
6. Greenberg B.D., Segal D.S. Acute and chronic behavioral interactions between phencyclidine (PCP) and amphetamine: evidence for a dopaminergic role in some PCP-induced behaviors. Pharmacol. Biochem. Behav. 23:1985;99-105.
7. 3H]paroxetine binding to rat cortical membranes. Eur. J. Pharmacol. 118:1985;107-114.
8. Hori T., Suzuki T., Baba A., Abe S., Yamamoto T., Moroji T., Shiraishi H. Effects of phencyclidine metabolites on serotonin uptake in rat brain. Neurosci. Lett. 209:1996;153-156.
9. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry. 148:1991;1301-1308.
10. Jentsch J.D., Taylor J.R., Elsworth J.D., Redmond D.E. Jr., Roth R.H. Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits. Neuroscience. 90:1999;823-832.
11. Johnson K.M., Jones S.M. Neuropharmacology of phencyclidine: basic mechanisms and therapeutic potential. Ann. Rev. Pharmacol. Toxicol. 30:1990;707-750.
12. Martin J.R., Berman M.H., Krewsun I., Small S.F. Phencyclidine-induced stereotyped behavior and serotonergic syndrome in rat. Life Sci. 24:1979;699-1704.
13. Martin P., Carlsson M.L., Hjorth S. Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats. NeuroReport. 9:1998;2985-2988.
14. Munson P.J., Rodbad D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:1980;220-239.
15. Nabeshima T., Yamaguchi K., Yamada K., Hiramatsu M., Furukawa H., Kameyama T. Phencyclidine-induced stereotyped behaviors in rats following specific neurotoxin lesions of the striatum. Eur. J. Pharmacol. 93:1983;229-234.
16. Nabeshima T., Noda Y., Matsuno K., Furukawa H., Kameyama T. Phencyclidine interacts with serotonin2 receptor, but not serotonin1 receptor. Res. Commun. Subst. Abuse. 5:1984;81-87.
17. Nabeshima T., Noda Y., Yamaguchi K., Ishikawa K., Furukawa H., Kameyama T. Acute and chronic phencyclidine administration changes serotonin receptors in rat brain. Eur. J. Pharmacol. 109:1985;129-130.
18. Nabeshima T., Fukaya H., Yamaguchi K., Ishikawa K., Furukawa H., Kameyama T. Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine. Eur. J. Pharmacol. 135:1987;23-33.
19. Nestler E.J., Duman R.S. Intracellular messenger pathways as mediators of neural plasticity. Bloom F.E., Kupfer D.J. Psychopharmacology. 4th edn. 1995;695-704 Raven Press, New York.
20. 3H]serotonin uptake in synaptosomal preparations from rat brain. Biochem. Parmacol. 26:1977;1435-1439.
21. Sturgeon R.D., Fessler R.G., London S.F., Meltzer H.Y. Behavioral effects of chronic phencyclidine administration in rats. Psychopharmacology. 76:1982;52-56.
22. Tonge S.R., Leonard B.E. The effects of some hallucinogenic drugs upon the metabolism of 5-hydorxy-tryptamine in the brain. Life Sci. 8:1969;805-814.
23. Young A.M., Goudie A.J. Adaptive processes regulating tolerance to behavioral effects of drugs. Bloom F.E., Kupfer D.J. Psychopharmacology. 4th edn. 1995;733-742 Raven Press, New York.